An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease — Stella

Home/Type II Gaucher Disease/

View on ClinicalTrials.gov

Recruiting

Back to Type II Gaucher Disease trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality

Key details

Phase

Very early testing

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

Shanghai Vitalgen BioPharma Co., Ltd.

Enrollment target

~6 participants

Started

March 2023

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

0 Months – 24 Months

Last updated February 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.